The panel reflects on dermatology's evolving role in CSU, from limited options and reluctance to a new era of empowered, effective disease management.
Challenging Hives: Optimizing Diagnosis and Management of CSU
The panel reviews the first patient case—a 38-year-old woman with recurrent hives and intermittent swelling—highlighting the key clinical criteria that clinch a CSU diagnosis.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis Down to Age 2
2
Evommune's EVO756 Misses Primary End Point in Phase 2b CSU Trial, Development Continues in AD and Migraine
3
Dermatology Times June 2026 Recap
4
Why Joint Damage Inhibition Matters in Psoriatic Arthritis Treatment
5